Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Marketing Surveillance To Observe Safety Of Prevenar 13

NCT01509105 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01509105
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01509105 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Marketing Surveillance To Observe Safety Of Prevenar 13
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
September 30, 2011
Completion date
January 31, 2016
Enrollment
649 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

healthy